Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Malaria
Interventions
DRUG

Amodiaquine-Artesunate

If necessary, the study drug will be crushed, dissolved in water and squirted into the mouth using a spoonful. Administration of the treatments will be directly observed. After drug administration, patients will be kept for at least 30 minutes in the clinic. A dose will be repeated in full if vomiting occurs within 30 minutes of administration and halved if vomiting is between 30 minutes and 1 hour post dosing.

DRUG

Artemether-lumefantrine

If necessary, the study drug will be crushed, dissolved in water and squirted into the mouth using a spoonful. Administration of the treatments will be directly observed. After drug administration, patients will be kept for at least 30 minutes in the clinic. A dose will be repeated in full if vomiting occurs within 30 minutes of administration and halved if vomiting is between 30 minutes and 1 hour post dosing.

Trial Locations (1)

218

Clinical Reaserch Unit, Nanoro

All Listed Sponsors
collaborator

Institute of Tropical Medicine, Belgium

OTHER

lead

Centre Muraz

OTHER

NCT01697787 - Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso | Biotech Hunter | Biotech Hunter